Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Radiation: Applications01:17

Radiation: Applications

The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
Absorption of Radiation01:05

Absorption of Radiation

The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

[Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation.

Clinical and translational radiation oncology·2022
Same author

[Re-irradiation of bone marrow compression on a focus of extra medullary hematopoiesis: Presentation of a case].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022

Related Experiment Video

Updated: Jun 21, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

[Total body irradiation: present and future].

T Zilli1, R Miralbell, M Ozsahin

  • 1Service de radio-oncologie, hôpitaux universitaires de Genève, 24, 1211 Genève 14, Suisse. Thomas.Zilli@hcuge.ch

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|July 21, 2009
PubMed
Summary

Total body irradiation (TBI) is a key preparative regimen for bone-marrow transplantation, but causes significant toxicity. Intensity-modulated TBI shows promise in reducing toxicity, potentially expanding treatment options for hematological malignancies.

More Related Videos

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
09:10

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation

Published on: July 27, 2022

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
09:10

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation

Published on: July 27, 2022

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Area of Science:

  • Radiation Oncology
  • Hematology
  • Medical Physics

Context:

  • Total body irradiation (TBI) is a standard preparative regimen for bone-marrow transplantation in hematological malignancies.
  • While effective, TBI is associated with significant acute and late toxicities, limiting its application.

Purpose:

  • To review current indications for TBI in clinical practice.
  • To analyze technological advancements in TBI delivery.
  • To evaluate the potential of intensity-modulated TBI (IM-TBI) in reducing toxicity and expanding indications.

Summary:

  • Randomized trials confirm the efficacy of TBI combined with cyclophosphamide for hematological malignancies.
  • Intensity-modulated radiotherapy (IMRT) enables selective irradiation of hematopoietic and lymphoid organs, forming the basis of IM-TBI.
  • Preliminary results suggest IM-TBI can mitigate treatment-related toxicity, potentially allowing for dose escalation and broader patient eligibility.

Impact:

  • Reduced treatment-related toxicity may overcome a major limitation in bone-marrow transplantation preparative regimens.
  • IM-TBI could expand TBI indications to older patients (>50 years) and permit dose escalation.
  • Further clinical trials are necessary to validate the impact of IM-TBI on disease control and long-term toxicity.